RSS   Newsletter   Contact   Advertise with us
Post Online Media

MiMedx Group names Luis A. Aguilar as director

Luis A. AguilarMiMedx Group, a regenerative medicine company, appointed Luis A. Aguilar, former Commissioner of the U.S. Securities and Exchange Commission (SEC), as an independent, non-employee director of the MiMedx board of directors.
Article continues below

READ MORE Calfrac announces leadership team appointments

Mr. Aguilar was appointed to be a SEC Commissioner by President George W. Bush in 2008.

Mr. Aguilar was reappointed by President Barack Obama in 2011 and served in that capacity until December 2015 when his term expired.

Mr. Aguilar is the eighth longest standing Commissioner in SEC history and one of only three Commissioners to have been nominated by two U.S. Presidents from two different political parties.

Prior to his appointment as an SEC Commissioner, he was a partner with the international law firm of McKenna Long & Aldridge, LLP (subsequently merged with Dentons US LLP).

Commissioner Aguilar's previous experience includes serving as the General Counsel, Head of Compliance, Executive Vice President, and Corporate Secretary of Invesco Inc., with responsibility for all legal and compliance matters regarding Invesco Institutional.

While at Invesco, he was also Managing Director for Latin America in the 1990's, and President of one of Invesco's broker-dealers.

Mr. Aguilar's career also includes tenure as a partner at several prominent national law firms: Alston & Bird LLP; Kilpatrick Townsend & Stockton LLP; and Powell Goldstein Frazer & Murphy LLP (subsequently merged with Bryan Cave LLP). He began his legal career as an attorney at the SEC.

During his service as an SEC Commissioner, Mr. Aguilar represented the SEC as its liaison to both the North American Securities Administrators Association (NASAA) and to the Council of Securities Regulators of the Americas (COSRA).

He also served as the primary sponsor of the SEC's first Investor Advisory Committee.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy